Computational Models to Assign Biopharmaceutics Drug Disposition Classification from Molecular Structure-Reference-Cited by-同舟云学术

Computational Models to Assign Biopharmaceutics Drug Disposition Classification from Molecular Structure

Published:2007-09-11 Issue:12 Volume:24 Page:2249-2262
ISSN:0724-8741
Container-title:Pharmaceutical Research
language:en
Short-container-title:Pharm Res

Author:

Khandelwal Akash,Bahadduri Praveen M.,Chang Cheng,Polli James E.,Swaan Peter W.,Ekins Sean

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Organic Chemistry,Pharmaceutical Science,Pharmacology,Molecular Medicine,Biotechnology

Link

http://link.springer.com/content/pdf/10.1007/s11095-007-9435-9.pdf

Reference172 articles.

1. WHO. Waiver of in vivo bioavailability and bioequivalence studies for immediate-release solid oral dosage forms based on a biopharmaceutics classification system. FDA guidance for industry, federal drug and food administration, Rockville, MD (2002).

2. H. H. Blume and B. S. Schug. The biopharmaceutics classification system (BCS): class III drugs—better candidates for BA/BE waiver? Eur. J. Pharm. Sci. 9:117–121 (1999).

3. J. E. Polli, L. X. Yu, J. A. Cook, G. L. Amidon, R. T. Borchardt, B. A. Burnside, P. S. Burton, M. L. Chen, D. P. Conner, P. J. Faustino, A. A. Hawi, A. S. Hussain, H. N. Joshi, G. Kwei, V. H. Lee, L. J. Lesko, R. A. Lipper, A. E. Loper, S. G. Nerurkar, J. W. Polli, D. R. Sanvordeker, R. Taneja, R. S. Uppoor, C. S. Vattikonda, I. Wilding, and G. Zhang. Summary workshop report: biopharmaceutics classification system-implementation challenges and extension opportunities. J. Pharm. Sci. 93:1375–1381 (2004).

4. N. A. Kasim, M. Whitehouse, C. Ramachandran, M. Bermejo, H. Lennernas, A. S. Hussain, H. E. Junginger, S. A. Stavchansky, K. K. Midha, V. P. Shah, and G. L. Amidon. Molecular properties of WHO essential drugs and provisional biopharmaceutical classification. Mol. Pharm. 1:85–96 (2004).

5. M. Lindenberg, S. Kopp, and J. B. Dressman. Classification of orally administered drugs on the World Health Organization Model list of Essential Medicines according to the biopharmaceutics classification system. Eur. J. Pharm. Biopharm. 58:265–278 (2004).

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Investigating pharmacokinetic profiles of Centella asiatica using machine learning and PBPK modelling;Journal of Biopharmaceutical Statistics;2024-06-11

2. Next-Gen Pharma;Advances in Healthcare Information Systems and Administration;2024-04-22

3. Artificial Intelligence and Machine Learning in Pharmacokinetics and Pharmacodynamic Studies;Pharmacokinetics and Pharmacodynamics of Novel Drug Delivery Systems: From Basic Concepts to Applications;2024

4. Mapping AI's Impact on Pharmaceuticals;AI and IoT-Based Technologies for Precision Medicine;2023-10-18

5. Selected Aspects of the Analytical and Pharmaceutical Profiles of Nifurtimox;Journal of Pharmaceutical Sciences;2023-06